Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$8.24M Buy
94,240
+7,379
+8% +$658K 0.13% 284
2017
Q3
$7.68M Sell
86,861
-62,432
-42% -$5.29M 0.14% 261
2017
Q2
$12.2M Sell
149,293
-14,056
-9% -$1.07M 0.26% 60
2017
Q1
$11.3M Buy
+163,349
New +$11.3M 0.25% 78
2016
Q4
Sell
-4,780
Closed -$349K 1177
2016
Q3
$349K Sell
4,780
-2,393
-33% -$169K 0.01% 944
2016
Q2
$493K Buy
+7,173
New +$503K 0.03% 609
2016
Q1
Sell
-4,375
Closed -$330K 821
2015
Q4
$330K Sell
4,375
-21,794
-83% -$1.57M 0.03% 587
2015
Q3
$1.7M Sell
26,169
-35,986
-58% -$2.38M 0.27% 123
2015
Q2
$4M Buy
62,155
+55,168
+790% +$3.72M 0.16% 284
2015
Q1
$491K Sell
6,987
-1,652
-19% -$109K 0.02% 643
2014
Q4
$561K Sell
8,639
-7,936
-48% -$490K 0.03% 642
2014
Q3
$894K Buy
+16,575
New +$901K 0.07% 371

Other funds holding STE

AHL Partners's STE Position: Q4 2017 in Review

AHL Partners increased its Steris (STE) stake by 8.5% in Q4 2017, buying an estimated $658K and bringing the position to 94,240 shares worth $8.24M. The position accounts for 0.13% of the portfolio, ranked #284.

AHL Partners first reported a position in STE in Q3 2014 and has held it in 12 quarters since. The position peaked at $12.2M in Q2 2017. 334 funds tracked by Wall St. Rank hold STE as of Q4 2017.

  • AHL Partners held 94,240 shares of Steris worth $8.24M as of Q4 2017.
  • AHL Partners bought 7,379 Steris shares in Q4 2017, an estimated $658K.
  • Steris made up 0.13% of AHL Partners's portfolio in Q4 2017, its #284 holding.
  • AHL Partners first reported a position in Steris in Q3 2014 and has held it in 12 quarters since.
  • AHL Partners's Steris position peaked at $12.2M in Q2 2017.
  • 334 funds tracked by Wall St. Rank held Steris as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.